Bio Key International (BKYI) Gains from Investment Securities (2016 - 2022)
Bio Key International (BKYI) has disclosed Gains from Investment Securities for 11 consecutive years, with $140000.0 as the latest value for Q3 2022.
- Quarterly Gains from Investment Securities changed N/A to $140000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $55989.0 through Dec 2022, down 42.27% year-over-year, with the annual reading at $186000.0 for FY2022, 86.0% up from the prior year.
- Gains from Investment Securities hit $140000.0 in Q3 2022 for Bio Key International, up from $55989.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $351918.0 in Q4 2018 to a low of $40995.0 in Q1 2020.
- Historically, Gains from Investment Securities has averaged $147225.5 across 3 years, with a median of $97994.5 in 2020.
- Biggest YoY gain for Gains from Investment Securities was 71.49% in 2018; the steepest drop was 71.49% in 2018.
- Year by year, Gains from Investment Securities stood at $351918.0 in 2018, then tumbled by 84.09% to $55989.0 in 2020, then surged by 150.05% to $140000.0 in 2022.
- Business Quant data shows Gains from Investment Securities for BKYI at $140000.0 in Q3 2022, $55989.0 in Q2 2020, and $40995.0 in Q1 2020.